Medical Scientist Training Program Student Wins ASH Award
Katelyn Melgar, a student in the College of Medicines Medical Scientist Training Program, received a 2015 Minority Graduate Student Abstract Achievement Award from the American Society of Hematology (ASH) and presented her abstract, titled "Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML, at the 57th ASH annual meeting Dec. 5-8 in Orlando.
Each year, ASH offers these awards, which are merit-based, to select graduate students to acknowledge the accomplishments of and retain minority graduate students in the field of hematology through exposure to its annual meeting.
Melgars focus is on immunology, and shes currently in the lab of Daniel Starczynowski, PhD, associate professor in UCs Department of Pediatrics and a researcher in the Division of Experimental Hematology and Cancer Biology at Cincinnati Childrens Hospital Medical Center.
Katelyn Melgar, a student in the College of Medicine s Medical Scientist Training Program, with her winning abstract.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.